This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Pfizer Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovations of Sabine Susanne Wellnitz
Introduction
Sabine Susanne Wellnitz is a notable inventor based in Nanuet, NY (US). She has made significant contributions to the field of immunology through her innovative research and development of immunogenic compositions. Her work is particularly relevant in the context of developing methods to elicit immune responses against specific infections.
Latest Patents
Wellnitz holds a patent for her invention titled "Immunogenic compositions against and methods thereof." This patent describes an immunogenic composition that includes atoxoid A and/or atoxoid B, along with methods for its use. The invention outlines a method for eliciting an immune response in humans against infections, which involves administering an effective dose of the composition at least two times to sustain the immune response against toxin A and/or toxin B.
Career Highlights
Sabine Wellnitz is currently associated with Pfizer Corporation, a leading pharmaceutical company known for its commitment to advancing healthcare through innovative solutions. Her role at Pfizer allows her to contribute to groundbreaking research and development in the field of immunology.
Collaborations
Throughout her career, Wellnitz has collaborated with esteemed colleagues, including Annaliesa Sybil Anderson and Alexey Vyacheslavovitch Gribenko. These collaborations have further enhanced her research and contributed to the advancement of immunogenic compositions.
Conclusion
Sabine Susanne Wellnitz exemplifies the spirit of innovation in the field of immunology. Her patent and work at Pfizer Corporation highlight her dedication to improving human health through scientific advancements. Her contributions are invaluable in the ongoing fight against infections and the development of effective immunogenic therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
